Breast Cancer

Breast Cancer Worldwide: Rates, Risks & Treatment Evolution

Breast cancer is now the most common cancer in women, with 2.3 million diagnoses in 2022. See which countries are hit hardest, why India records the most deaths, and how treatment has changed.

Dr. Sujata Mittal9 October 2026 5 min read
Breast Cancer Worldwide: Rates, Risks & Treatment Evolution

Breast cancer is now the most common cancer in women worldwide. In 2022, about 2.3 million women were diagnosed with it and roughly 666,000 died, according to GLOBOCAN estimates from the World Health Organization’s cancer agency. But the numbers tell different stories depending on where you look. Wealthy nations record the highest rates, while India, with a much lower rate, reports the most deaths of any country. At the same time, treatment has moved far from the radical surgery of the 1970s toward precise, tumour-specific care. This article looks at who is most affected, why outcomes differ so widely, and how treatment has evolved.

Which Countries Have the Highest Breast Cancer Rates?

Wealthy nations top the global charts for breast cancer, measured as new cases per 100,000 women (age-standardised). France and Cyprus lead at 105, followed by Belgium (104), the Netherlands (102) and Australia (102). The United States (96) and the United Kingdom (94) are close behind. Several factors push these numbers up. Women in these countries tend to have children later in life and have fewer children, both of which raise breast cancer risk. Obesity and alcohol use add to it. Widespread screening also plays a role, because mammography programmes find more cancers, including small ones that might otherwise go unnoticed.

Countries With the Most Breast Cancer Cases and Deaths

The countries with the largest number of women affected are not the same as those with the highest rates. China recorded about 357,000 cases in 2022, the United States 274,000 and India 192,000. Asia as a whole accounts for nearly 985,000 cases, more than any other continent. India’s rate is comparatively low, at 26.6 per 100,000 women, yet it reported about 98,000 deaths in 2022, the most of any country. Late presentation is a major reason. Many women see a doctor only when the disease has already spread, which makes treatment harder and survival lower. Earlier diagnosis could change this picture more than any new drug.

How Breast Cancer Treatment Has Changed Over 50 Years

Until the 1970s, the standard operation was the Halsted radical mastectomy, which removed the breast, chest muscles and underarm nodes. Trials in the 1970s and 80s then proved that lumpectomy with radiotherapy gives the same survival as mastectomy for early cancers, and tamoxifen began the era of hormone therapy. The 1990s brought sentinel node biopsy, which spared most women a full underarm clearance and the painful swelling (lymphoedema) that can follow it. Aromatase inhibitors joined hormone treatment. From 1998, trastuzumab (Herceptin) turned HER2-positive cancer from one of the most aggressive subtypes into one of the most treatable. Today, treatment follows tumour biology. Chemotherapy or targeted drugs are often given before surgery, genomic tests spare many women unnecessary chemotherapy, and newer options such as CDK4/6 inhibitors, PARP inhibitors, antibody-drug conjugates and immunotherapy are used for carefully selected patients. The direction is clear: less surgery, more precision and better survival. Even so, the biggest gain still comes from finding cancer early, when a small lump can be treated with a small operation.

Early detection saves lives. If you notice a lump or any change in your breast, don’t wait. Speak to a specialist today.